CAPTIA MEASLES IGM

Enzyme Linked Immunoabsorbent Assay, Rubeola Igm

TRINITY BIOTECH USA

The following data is part of a premarket notification filed by Trinity Biotech Usa with the FDA for Captia Measles Igm.

Pre-market Notification Details

Device IDK140455
510k NumberK140455
Device Name:CAPTIA MEASLES IGM
ClassificationEnzyme Linked Immunoabsorbent Assay, Rubeola Igm
Applicant TRINITY BIOTECH USA 2823 Girts Rd Jamestown,  NY  14701
ContactBonnie B Dejoy
CorrespondentBonnie B Dejoy
TRINITY BIOTECH USA 2823 Girts Rd Jamestown,  NY  14701
Product CodePCL  
CFR Regulation Number866.3520 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2014-02-24
Decision Date2014-05-22
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
05391516743655 K140455 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.